RNU6-299P

Across TCGA pan-cancer cohorts, RNU6-299P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU6-299P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU6-299P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-299P expression acts as an unfavorable survival marker.

KIRP, THCA, and UVM are the cancer types where RNU6-299P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.621	0.874	<.001	117	view →
THCA	OS	Tertile	IV	0.095	0.955	<.001	81	view →
UVM	OS	Tertile	III,IV	0.178	0.933	<.001	63	view →
COAD	DFS	Tertile	II,III,IV	0.165	0.661	.038	36	view →
LIHC	OS	Tertile	All	0.599	0.788	.009	21	view →
GBM	OS	Tertile	All	0.129	0.418	.009	18	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
BLCA	DFS	Tertile	III,IV	0.152	0.572	.031	18	view →
KIRC	DFS	Tertile	IV	0.209	0.489	.047	18	view →
TGCT	OS	Tertile	All	0.694	0.968	.001	18	view →
LUSC	OS	Tertile	III,IV	0.147	0.664	.028	18	view →
KICH	OS	Tertile	All	0.648	0.972	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU6-299P–KIRP (DFS)

Open the KIRP breakdown →